vaccine
TW202627098APending Publication Date: 2026-07-01ASTRAZENECA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114144415
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-15
- Filing Date
- 2025-11-14
- Publication Date
- 2026-07-01
Abstract
The present disclosure relates to an mRNA molecule encoding a polypeptide comprising an hMPV F protein, or an immunogenic fragment thereof, and a lumazine synthase (LuS) capable of multimerising to form a nanoparticle. Further aspects of the disclosure relate to compositions comprising the mRNA molecule and their use as a vaccine in the prevention of infectious diseases, including those caused by hMPV and RSV.
Need to check novelty before this filing date? Find Prior Art